Abstract: A multi-channel radio frequency transceiving device includes an optical module, a digital signal processing module, a radio frequency transceiving module, a downlink module, and a microprocessing module. The optical module receives an optical signal corresponding to baseband data, converts the optical signal into an electric signal, and outputs the electric signal to the digital signal processing module. The digital signal processing module obtains the baseband data and channel number information on the basis of the electric signal, and allocates and processes the baseband data. The microprocessing module determines the number of working channels of the radio frequency transceiving module, the corresponding number of working channels of the downlink module and a downlink output power on the basis of the channel number information and the baseband data, and closes the remaining channels in the downlink module.

Abstract: An ROF communication remote machine and an ROF system are disclosed. The machine comprises a first packaging module and a second packaging module. The first packaging module comprises a first branch and a second branch. The first branch is used for converting a downlink optical signal, and sending the downlink electrical signal to the second packaging module. The second branch receives the downlink electrical signal, converts the downlink electrical signal into a downlink optical signal, sends the downlink optical signal to the local machine, receives an uplink electrical signal, and sends the uplink electrical signal to the local machine. The second packaging module is used for amplifying the power of the downlink electrical signal, filtering the downlink electrical signal, then feeding back the downlink electrical signal to another component, receiving the uplink electrical signal, and sending the uplink electrical signal to the second port.

Abstract: In one aspect of the present disclosure, a method of acquiring gesture data is provided. The method may include acquiring a gesture signal. The method may include acquiring a feature value corresponding to the gesture signal. The method may include acquiring a signal state corresponding to a feature point based on the feature value, adding the feature value and the signal state to a gesture signal set. The method may include acquiring all feature values and all signal states between a gesture start point and a gesture end point in the phase of acquiring the gesture data from the gesture signal set. The method may include generating signal change information based on the all feature values and the all signal states. The method may include identifying the signal change information as a signal data segment of a target gesture in response to the signal change information meeting signal verification information.

Abstract: A millimeter-wave active antenna unit and an interconnection structure between PCBs is provided. The interconnection structure between PCBs comprises a mainboard and an AIP antenna module. The mainboard is a first multilayer PCB on which a signal transmission line and a first pad electrically connected to the signal transmission line are provided. The AIP antenna module is a second multilayer PCB on which a second pad, an impedance matching transformation branch, an impedance line and a signal processing circuit are provided. The mainboard and the AIP antenna module are interconnected by directly welding multiple PCBs.

Abstract: An ROF communication remote machine and an ROF system are disclosed. The machine comprises a first packaging module and a second packaging module. The first packaging module comprises a first branch and a second branch The first branch is used for converting a downlink optical signal, and sending the downlink electrical signal to the second packaging module. The second branch receives the downlink electrical signal, converts the downlink electrical signal into a downlink optical signal, sends the downlink optical signal to the local machine, receives an uplink electrical signal, and sends the uplink electrical signal to the local machine. The second packaging module is used for amplifying the power of the downlink electrical signal, filtering the downlink electrical signal, then feeding back the downlink electrical signal to another component, receiving the uplink electrical signal, and sending the uplink electrical signal to the second port.

Abstract: Provided herein are methods and compositions for treating liver disorders, including without limitation non-alcoholic steatohepatitis, and symptoms and manifestations thereof, in a patient.

Abstract: A millimeter-wave active antenna unit and an interconnection structure between PCBs is provided. The interconnection structure between PCBs comprises a mainboard and an AIP antenna module. The mainboard is a first multilayer PCB on which a signal transmission line and a first pad electrically connected to the signal transmission line are provided. The AIP antenna module is a second multilayer PCB on which a second pad, an impedance matching transformation branch, an impedance line and a signal processing circuit are provided. The mainboard and the AIP antenna module are interconnected by directly welding multiple PCBs.

Abstract: Provided herein are prodrugs of 5-fluorodeoxyuridine monophosphate compounds, compositions thereof, methods of their preparation, and their use in treating cancers. In another aspect, provided herein is a pharmaceutical composition comprising any compound disclosed herein, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier, diluent, and excipient.

Abstract: Provided herein are methods and compositions for treating liver disorders, including without limitation non-alcoholic steatohepatitis, and symptoms and manifestations thereof, in a patient. Accordingly, utilized herein are compounds of formulas (I), (II), etc., as disclosed herein.

Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions for treatment of viral infections, especially HRV.

Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions for treatment of viral infections, especially HRV.

Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions for treatment of viral infections, especially HRV.

Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.

Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent, and methods of using the compounds and compositions for treatment of viral infections, especially HRV.

Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.

Abstract: This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are as defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue fever, yellow fever, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.

Abstract: This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Abstract: The present invention provides a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein B, Q, R1, R5, R6, R7, R8 and Z are as defined herein, which is a 2?-branched nucleoside useful for the treatment or prevention of viral infections, particularly dengue fever, yellow fever, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, Kunjin virus, Murray Valley encephalitis, St Louis encephalitis, Omsk hemorrhagic fever virus, bovine viral diarrhea virus, Zika virus and Hepatitis C virus.

Abstract: This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.